US2005048518A1PendingUtilityA1
Laminin chains: diagnostic and therapeutic use
Priority: Oct 4, 1994Filed: Dec 11, 2003Published: Mar 3, 2005
Est. expiryOct 4, 2014(expired)· nominal 20-yr term from priority
G01N 33/57535G01N 33/5758G01N 33/5755G01N 33/5751Y10S436/813C12Q 2600/158C07K 16/28G01N 2474/20C12Q 1/6886G01N 2333/78
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The instant invention provides for the identification, diagnosis, monitoring, and treatment of invasive cells using the laminin 5 gamma-2 chain protein or nucleic acid sequence, or antibodies thereto.
Claims
exact text as granted — not AI-modified1 - 33 . (Canceled)
34 . A method for inhibiting tumor cell invasion of non-malignant tissue, comprising administering to an individual in need thereof an antibody to a laminin 5 gamma 2 chain to inhibit tumor cell invasion of non-malignant tissue in the individual.
35 . The method of claim 34 wherein the antibody is a polyclonal antibody.
36 . The method of claim 34 wherein the antibody is a monoclonal antibody.
37 . A method for inhibiting the budding of tumor masses, comprising administering to an individual in need thereof an antibody to a laminin 5 gamma 2 chain to inhibit budding of tumor masses in the individual.
38 . The method of claim 37 wherein the antibody is a polyclonal antibody.
39 . The method of claim 37 wherein the antibody is a monoclonal antibody.
40 . A method for inhibiting tumor cell interaction with basement membrane, comprising administering to an individual in need thereof an antibody to a laminin 5 gamma 2 chain to inhibit tumor cell interaction with basement membrane in the individual.
41 . The method of claim 40 wherein the antibody is a polyclonal antibody.
42 . The method of claim 40 wherein the antibody is a monoclonal antibody.Join the waitlist — get patent alerts
Track US2005048518A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.